[go: up one dir, main page]

AP2007004058A0 - Novel spirotropane compounds and methods for the modulation of chemokine receptor activity - Google Patents

Novel spirotropane compounds and methods for the modulation of chemokine receptor activity

Info

Publication number
AP2007004058A0
AP2007004058A0 AP2007004058A AP2007004058A AP2007004058A0 AP 2007004058 A0 AP2007004058 A0 AP 2007004058A0 AP 2007004058 A AP2007004058 A AP 2007004058A AP 2007004058 A AP2007004058 A AP 2007004058A AP 2007004058 A0 AP2007004058 A0 AP 2007004058A0
Authority
AP
ARIPO
Prior art keywords
modulation
methods
chemokine receptor
receptor activity
novel
Prior art date
Application number
AP2007004058A
Other languages
English (en)
Inventor
Chung Kong Laval Chan
Marc Courchesne
Louis Baillan-Court
Original Assignee
Virochem Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virochem Pharma Inc filed Critical Virochem Pharma Inc
Publication of AP2007004058A0 publication Critical patent/AP2007004058A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AP2007004058A 2004-12-09 2005-12-09 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity AP2007004058A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63426604P 2004-12-09 2004-12-09
US69305105P 2005-06-23 2005-06-23
PCT/CA2005/001878 WO2006060919A1 (en) 2004-12-09 2005-12-09 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity

Publications (1)

Publication Number Publication Date
AP2007004058A0 true AP2007004058A0 (en) 2007-08-31

Family

ID=36577643

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007004058A AP2007004058A0 (en) 2004-12-09 2005-12-09 Novel spirotropane compounds and methods for the modulation of chemokine receptor activity

Country Status (13)

Country Link
US (1) US7960403B2 (xx)
EP (1) EP1831222A4 (xx)
JP (1) JP2008522986A (xx)
KR (1) KR20070095310A (xx)
AP (1) AP2007004058A0 (xx)
AU (1) AU2005313813B2 (xx)
BR (1) BRPI0518859A2 (xx)
CA (1) CA2587508A1 (xx)
EA (1) EA200701248A1 (xx)
MX (1) MX2007006776A (xx)
NZ (1) NZ555624A (xx)
SG (1) SG158111A1 (xx)
WO (1) WO2006060919A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7709642B2 (en) 2004-06-25 2010-05-04 Virochem Pharma, Inc. Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
AP2007004058A0 (en) 2004-12-09 2007-08-31 Virochem Pharma Inc Novel spirotropane compounds and methods for the modulation of chemokine receptor activity
EP1824853A4 (en) 2004-12-09 2010-06-09 Virochem Pharma Inc NEW SPIROTROPAN COMPOUNDS AND METHOD FOR MODULATING THE ACTIVITY OF THE CHEMOKIN RECEPTOR
CA2655203A1 (en) * 2006-06-14 2007-12-21 Virochem Pharma Inc. Spirotropane compounds
RU2565766C1 (ru) * 2014-11-17 2015-10-20 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии и регенеративной медицины имени Е.Л. Гольдберга" 4-(3,4-дибромтиофенкарбонил)-2,6,8,12-тетраацетил-2,4,6,8,10,12-гексаазатетрацикло[5,5,0,03,11,05,9]додекан в качестве анальгетического средства и способ его получения
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852029A (en) * 1990-04-10 1998-12-22 Israel Institute For Biological Research Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
US5407938A (en) * 1990-04-10 1995-04-18 Israel Institute For Biological Research Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines)
US6166209A (en) 1997-12-11 2000-12-26 Hoffmann-La Roche Inc. Piperidine derivatives
AU2001241056A1 (en) 2000-03-09 2001-09-17 Mitsubishi Pharma Corporation Spiro compounds, process for preparing the same and use thereof as drugs
DE60122753T2 (de) 2000-08-17 2007-08-16 Merck & Co., Inc. Cyclopentylmodulatoren der chemokin-rezeptor-aktivität
WO2004041279A1 (en) * 2002-10-30 2004-05-21 Merck & Co., Inc. Gamma-aminoamide modulators of chemokine receptor activity
CA2573951A1 (en) 2003-07-18 2005-01-27 Virochem Pharma Inc. Spiro compounds and methods for the modulation of chemokine receptor activity
CA2579608A1 (en) 2003-09-10 2005-03-17 Virochem Pharma Inc. Spiro compounds and methods for the modulation of chemokine receptor activity
EP1786816A4 (en) 2003-09-10 2009-11-04 Virochem Pharma Inc SPIROHYDANTOIN COMPOUNDS AND METHODS FOR MODULATING CHEMOKINE RECEPTOR ACTIVITY
US7709642B2 (en) 2004-06-25 2010-05-04 Virochem Pharma, Inc. Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
AP2007004058A0 (en) 2004-12-09 2007-08-31 Virochem Pharma Inc Novel spirotropane compounds and methods for the modulation of chemokine receptor activity
EP1824853A4 (en) 2004-12-09 2010-06-09 Virochem Pharma Inc NEW SPIROTROPAN COMPOUNDS AND METHOD FOR MODULATING THE ACTIVITY OF THE CHEMOKIN RECEPTOR
CA2655203A1 (en) 2006-06-14 2007-12-21 Virochem Pharma Inc. Spirotropane compounds

Also Published As

Publication number Publication date
AU2005313813A1 (en) 2006-06-15
AU2005313813B2 (en) 2011-04-14
US7960403B2 (en) 2011-06-14
KR20070095310A (ko) 2007-09-28
EP1831222A1 (en) 2007-09-12
JP2008522986A (ja) 2008-07-03
SG158111A1 (en) 2010-01-29
NZ555624A (en) 2009-09-25
US20080267906A1 (en) 2008-10-30
EA200701248A1 (ru) 2007-12-28
WO2006060919A1 (en) 2006-06-15
MX2007006776A (es) 2007-07-09
CA2587508A1 (en) 2006-06-15
BRPI0518859A2 (pt) 2008-12-09
EP1831222A4 (en) 2009-10-21

Similar Documents

Publication Publication Date Title
EP1656138A4 (en) SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
IL181044A0 (en) Antagonizing interleukin-21 receptor activity
IL191554A0 (en) Lactam compounds and methods of using the same
IL189975A0 (en) Methods of modulating neurotrophin-mediated activity
IL186091A0 (en) Enzyme and receptor modulation
IL179508A0 (en) 2-substituted-4- heteroaryl-pyrimidines useful for the treatment of proliferative disorders
IL181104A0 (en) Methods and compositions for modulating sphingosine-1-phosphate (sip) receptor activity
TWI366458B (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
IL176720A0 (en) Chemokine ccr5 receptor modulators
ZA200803452B (en) Modulation of glucocorticoid receptor expression
IL164909A0 (en) Tetrahydropyranyl cyclopentyll tetrahydropidopyridine modulators of chemokine receptor activity
ZA200705086B (en) Catalytic materials and method for the preparation thereof
AP2006003849A0 (en) 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
AP2314A (en) 3- 4-heteroarylcyclohexylamino cyclopentanecarboxamides as modulators of chemokine receptors.
IL175958A0 (en) Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
IL179462A0 (en) Use of the receptor gpr86
EP1806147A4 (en) USE OF IMMUNOSUPPRESSIVE RECEPTOR
EP1786816A4 (en) SPIROHYDANTOIN COMPOUNDS AND METHODS FOR MODULATING CHEMOKINE RECEPTOR ACTIVITY
AP2007004058A0 (en) Novel spirotropane compounds and methods for the modulation of chemokine receptor activity
EP1631286A4 (en) N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
EP1824853A4 (en) NEW SPIROTROPAN COMPOUNDS AND METHOD FOR MODULATING THE ACTIVITY OF THE CHEMOKIN RECEPTOR
EP1805225A4 (en) CATALYST FOR PROPYLENE POLYMERIZATION AND PROCESS FOR PROPYLENE POLYMERIZATION USING THE CATALYST
EP1682105A4 (en) N-UREIDOALKYL-AMINO COMPOUNDS AS MODULATORS OF CHEMOKIN RECEPTOR ACTIVITY
ZA200804872B (en) Lactam compounds and methods of using the same
ZA200701015B (en) Antagonizing interleukin-21 receptor activity